NCT07283107

Brief Summary

Breast cancer is the leading cancer among women in Singapore, yet mammography screening rates remain critically low at 34.7%, despite the availability of a national program since 2002. This shortfall significantly limits the potential of screening to reduce mortality at a population level. While various behavioral interventions have been tested internationally to increase uptake, their applicability in the local context remains uncertain. Existing studies in Singapore are either outdated, small in scale, or not sufficiently targeted. In particular, two subgroups of women warrant closer examination due to the scarcity of data: (1) never-screeners: those who have never undergone a mammogram and (3) recent screeners: those who had a mammogram more than two years ago but have not scheduled their next one. These cohorts exhibit distinct behavioral and psychological barriers that prevent adherence to regular, guideline-recommended screening. E.g., key barriers for never- screeners include low perceived susceptibility to breast cancer, lack of awareness about the benefits of early detection, fear or anxiety about pain or receiving a cancer diagnosis, cultural or personal modesty concerns or lack of a physician's recommendation. In contrast, the repeat recent screeners often have a misconception that a single normal result is sufficient, negative experiences during prior screenings (e.g., false positives, pain), absence of reminder systems and competing life priorities and lack of time. Among these, engaging never-screeners is particularly challenging, as they may not perceive screening as personally relevant or necessary, and many have successfully avoided the healthcare system for years. Yet, failure to engage these groups; poses a significant public health concern, as it undermines the effectiveness of population-level cancer control strategies. The PROMPT study is designed to fill this critical gap by systematically evaluating multiple low-cost, scalable outreach strategies in two parallel randomized trials. Its findings will provide robust, local evidence to inform policy and improve engagement of these hard-to-reach populations.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,910

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Nov 2025Dec 2027

Study Start

First participant enrolled

November 17, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 2, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

1.1 years

First QC Date

December 2, 2025

Last Update Submit

December 21, 2025

Conditions

Keywords

MammographyBreast CancerCancer ScreeningEarly Cancer Detection

Outcome Measures

Primary Outcomes (1)

  • Comparison of Mammogram Uptake Between Interventional Arms (2-5) and Control Arm (Arm 1)

    Comparison of the proportion of women who undergo surveillance mammography among participants in Arms 2-5 versus Arm 1 (control arm).

    4 months from the time participants receive the reminders

Secondary Outcomes (3)

  • Impact of social and demographic factors on mammogram completion.

    4 months from the time participants receive the reminder

  • Post-trial telephone survey

    1-2 months post-trial

  • Mammogram uptake at 6 and 12 months post-trial

    6 and 12 months from the time participants received the first mailed reminder

Study Arms (5)

Control Arm (Arm 1)

NO INTERVENTION

Does not receive any reminder to go for mammogram.

Arm 2: : One mailed reminder

EXPERIMENTAL

Receives a single mail reminder

Behavioral: Arm 2: One mailed reminder

Arm 3: Two mailed reminders

EXPERIMENTAL

Receives two mail reminders, 1 month apart

Behavioral: Arm 3: Two mailed reminders

Arm 4: Mailed Reminder with Prescheduled Appointment

EXPERIMENTAL

Recieves a mailed reminder with prescheduled appointment

Behavioral: Arm 4: Mailed reminder with prescheduled appointment

Arm 5: Mailed reminder with enhanced messaging

EXPERIMENTAL

Receives mailed reminder with enhanced messaging

Behavioral: Arm 5: Mailed reminder with enhanced messaging

Interventions

Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram

Arm 2: : One mailed reminder

Receives a mailed reminder + follow-up mailed reminder, 1 month after the first reminder

Arm 3: Two mailed reminders

Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment

Arm 4: Mailed Reminder with Prescheduled Appointment

Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening

Arm 5: Mailed reminder with enhanced messaging

Eligibility Criteria

Age50 Years - 69 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales only
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Singaporean citizen
  • Age 50-69
  • Registered as a patient at the National University Hospital
  • Registered and active user of NUHS App
  • Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
  • For "never-screener" cohort: Must have never undergone mammogram screening
  • For "repeat-screener" cohort : Must have completed screening in the last 18-24 months but have not booked their next appointment yet

You may not qualify if:

  • Diagnosis of breast cancer in EPIC
  • Mammogram done in the past 24 months in EPIC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital Singapore

Singapore, Singapore

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Soo-Chin Lee, MBBS, MRCP

    National University Hospital Singapore, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2025

First Posted

December 15, 2025

Study Start

November 17, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

December 29, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations